Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £195.03m
BMD Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead 2vt Share Chart

Offer for Subscription - Update

8 Nov 2017 09:00

RNS Number : 8460V
Baronsmead Second Venture Trust PLC
08 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

BARONSMEAD SECOND VENTURE TRUST PLC

8 November 2017

Offer for Subscription - Update

On 4 October 2017, Baronsmead Second Venture Trust plc (the "Company") published a prospectus (the "Prospectus") in relation to an offer for subscription to raise up to £24 million (before costs) (the "Offer"). The Company announced on 26 October 2017 that it had raised gross proceeds of approximately £13.5 million pursuant to the Offer and accordingly had issued 13,797,365 New Shares at an Offer Price of 97.60 pence.

The Board of the Company is now pleased to announce that as at the close of business on 7 November 2017, the Company had raised gross proceeds of approximately £16.5 million in total pursuant to the Offer.

The Board has resolved to move the second allotment of New Shares under the Offer from 15 November 2017 to 17 November 2017 to allow Existing Shareholders and new investors additional time to submit their Subscription Forms. The Company will make a further announcement in relation to the second allotment, including the Offer Price at which the New Shares will be issued, in due course. In accordance with the terms of the Offer the Board has further resolved to extend the Offer period to 12 noon on 29 December 2017 or until such date as the Offer is fully subscribed, being no later than 29 December 2017.

Subscriptions will be processed by the Receiving Agent on a "first come, first served" basis. Existing Shareholders and new investors who wish to participate in the Offer should return a completed Subscription Form to the Receiving Agent, as set out in the Prospectus, as soon as possible.

Definitions

Terms defined in the Prospectus have the same meanings in this announcement unless the context requires otherwise.

Further information

For further information please contact.

Michael Probin - VCT investor relations

Livingbridge VC LLP

020 7506 5796

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPUBVBRBRAARAA
Date   Source Headline
4th Nov 20211:00 pmRNSPublication of a Prospectus
28th Oct 20213:00 pmRNSReplacement Net Asset Value(s)
21st Oct 20211:00 pmRNSNet Asset Value(s)
1st Oct 202111:36 amRNSTotal Voting Rights
29th Sep 20216:28 pmRNSTransaction in Own Shares
14th Sep 202111:29 amRNSSale of shares from Treasury
14th Sep 20219:36 amRNSUpdate on Offer for Subscription
7th Sep 20219:31 amRNSNet Asset Value(s)
5th Aug 20214:08 pmRNSIntention to Launch an Offer for Subscription
5th Aug 20213:00 pmRNSNet Asset Value(s)
2nd Aug 202112:42 pmRNSTotal Voting Rights
23rd Jul 20215:27 pmRNSTransaction in Own Shares
21st Jul 20219:30 amRNSNet Asset Value(s)
1st Jul 202110:29 amRNSTotal Voting Rights
9th Jun 20216:23 pmRNSTransaction in Own Shares
4th Jun 20216:00 pmRNSNet Asset Value(s)
27th May 20213:35 pmRNSHalf-year Report
7th May 20214:15 pmRNSNet Asset Value(s)
15th Apr 20215:00 pmRNSNet Asset Value(s)
1st Apr 202110:16 amRNSTotal Voting Rights
30th Mar 20216:01 pmRNSTransaction in Own Shares
18th Mar 20213:22 pmRNSIssue of New Shares
9th Mar 202112:03 pmRNSSale of shares from Treasury
3rd Mar 20215:15 pmRNSNet Asset Value(s)
2nd Mar 202112:41 pmRNSOffer for Subscription - Update
1st Mar 202112:43 pmRNSTotal Voting Rights
26th Feb 202111:26 amRNSIssue of New Shares
16th Feb 20215:14 pmRNSResult of AGM
15th Feb 20219:22 amRNSUpdate on Fundraising
5th Feb 202110:00 amRNSNet Asset Value(s)
1st Feb 202112:22 pmRNSTotal Voting Rights
29th Jan 20211:30 pmRNSIssue of New Shares
27th Jan 20215:30 pmRNSTransaction in Own Shares
27th Jan 202111:27 amRNSPublication of Supplementary Prospectus
21st Jan 20215:45 pmRNSNet Asset Value(s)
6th Jan 202110:37 amRNSUpdate on Fundraising
4th Jan 202112:05 pmRNSTotal Voting Rights
18th Dec 20207:00 amRNSIssue of Equity
17th Dec 20205:45 pmRNSTransaction in Own Shares
14th Dec 202012:27 pmRNSAppointment of Non-Executive Director
4th Dec 20204:15 pmRNSNet Asset Value(s)
3rd Dec 20206:00 pmRNSAnnual Financial Report For Y/E 30/09/20
1st Dec 202010:37 amRNSTotal Voting Rights
27th Nov 20201:05 pmRNSCorrection: Directorate Change
25th Nov 20203:51 pmRNSDirectorate Change
10th Nov 20203:08 pmRNSDirector/PDMR Shareholding
10th Nov 20202:58 pmRNSDirector/PDMR Shareholding
10th Nov 20202:44 pmRNSDirector/PDMR Shareholding
10th Nov 20202:41 pmRNSDirector/PDMR Shareholding
10th Nov 20201:44 pmRNSIssue of New Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.